The effect of age on plasma levels of propranolol and practolol in man.
1. Plasma levels of propranolol and practolol were measured in groups of elderly and young subjects, after the oral administration of propranolol (40 mg) and practolol (200 mg) on separate occasions. 2. At all sampling times the mean plasma propranolol level in the group of elderly subjects was substantially greater than the corresponding level in the group of young subjects, there being a significant difference between the two, and a fourfold difference in the mean peak levels. 3. After practolol, there was no significant difference between the mean plasma concentrations of the drug in the two groups for the first 2 hours. Subsequently, the mean plasma levels in the group of elderly subjects were somewhat higher than the corresponding levels in the young group, the differences between the two reaching significance. 4. It is suggested that there is a need to substantially reduce the dose of propranolol given to elderly patients. With practolol, however, no reduction is necessary providing renal function is normal for the patient's age.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000375:Aging; D005260:Female; D006207:Half-Life; D006801:Humans; D008297:Male; D011217:Practolol / Q000008:administration & dosage / Q000097:blood*; D011433:Propranolol / Q000008:administration & dosage / Q000097:blood*
D011433:Propranolol; D011217:Practolol